Atlas Trials

Safety, Tolerability, and Pharmacokinetics (PK) of CTP-499

Clinical trial NCT01328821 · COMPLETED

Trial details

NCT number
NCT01328821
Sponsor
Concert Pharmaceuticals
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Diabetic Nephropathy
Start date
2011-03-01
Primary completion
2011-04-01
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.